CFML
GSK icon

COMPASS FINANCIAL MANAGEMENT LLC’s GSK GSK Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34K Buy
+650
New +$34.4K ﹤0.01% 765

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's GSK Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in GSK (GSK) in Q2 2026: 650 shares worth $34K. The stake represents ﹤0.01% of the portfolio and ranks #765 among its holdings.

871 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • COMPASS FINANCIAL MANAGEMENT LLC held 650 shares of GSK worth $34K as of Q2 2026.
  • GSK was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
  • GSK made up ﹤0.01% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #765 holding.
  • 871 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.